Singapore markets closed

Straits Times Index
3,292.69
+10.64(+0.32%)
Nikkei
38,405.66
+470.90(+1.24%)
Hang Seng
17,763.03
+16.12(+0.09%)
FTSE 100
8,144.13
-2.90(-0.04%)
Bitcoin USD
62,955.66
-677.18(-1.06%)
CMC Crypto 200
1,291.50
-47.56(-3.55%)

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

3.8250

-0.0150

(-0.39%)

As of 01:47PM EDT. Market open.

Loading interactive chart…

Zacks
Analysts Estimate AbCellera Biologics Inc. (ABCL) to Report a Decline in Earnings: What to Look Out for
AbCellera Biologics (ABCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Business Wire
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
VANCOUVER, British Columbia, April 08, 2024--AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
Business Wire
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
VANCOUVER, British Columbia, April 03, 2024--AbCellera (Nasdaq: ABCL) will announce its first quarter 2024 financial results on Tuesday, May 7, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.